The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
The urokinase receptor: Focused cell surface proteolysis, cell adhesion and signaling
Abstract
uPAR is highly expressed during tissue reorganization, inflammation, and in virtually all human cancers. Since its discovery, in vitro and in vivo models, as well as retrospective clinical studies have shown that over‐expression of components of the uPA/uPAR‐system correlates with increased proliferation, migration, and invasion affecting the malignant phenotype of cancer. uPAR regulates the cells–extracellular matrix interactions promoting its degradation and turnover through the plasminogen activation cascade.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
uPAR: a versatile signalling orchestrator
Blasi, F., & Carmeliet, P. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm977 · Cited by 1,223
Self-citationRegulation of Integrin Function by the Urokinase Receptor
Wei, Y., Lukashev, M., Simon, D. I., Bodary, S. C., Rosenberg, S., Doyle, M. V., & Chapman, H. A. (1996) · Science · doi:10.1126/science.273.5281.1551 · Cited by 727
A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase.
Vassalli, J. D., Baccino, D., & Belin, D. (1985) · The Journal of cell biology · doi:10.1083/jcb.100.1.86 · Cited by 712
Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors
Blasi, F., Vassalli, J., & Danø, K. (1987) · The Journal of cell biology · doi:10.1083/jcb.104.4.801 · Cited by 617
Self-citationRoldan, A. L., Cubellis, M. V., Masucci, M. T., Behrendt, N., Lund, L. R., Danø, K., Appella, E., & Blasi, F. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08132.x · Cited by 603
Self-citationIdentification of the urokinase receptor as an adhesion receptor for vitronectin.
Wei, Y., Waltz, D. A., Rao, N., Drummond, R. J., Rosenberg, S., & Chapman, H. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31646-6 · Cited by 581
Ploug, M., Rønne, E., Behrendt, N., Jensen, A. L., Blasi, F., & Danø, K. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)52382-6 · Cited by 574
Self-citationGhiso, J. A. A., Kovalski, K., & Ossowski, L. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.1.89 · Cited by 549
Nykjaer, A., Petersen, C. M., Møller, B., Jensen, P. H., Moestrup, S. K., Holtet, T. L., Etzerodt, M., Thøgersen, H. C., Munch, M., & Andreasen, P. A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42072-8 · Cited by 459
Deng, G., Curriden, S. A., Wang, S., Rosenberg, S., & Loskutoff, D. J. (1996) · The Journal of cell biology · doi:10.1083/jcb.134.6.1563 · Cited by 448
Cited by
Endothelium—role in regulation of coagulation and inflammation
van Hinsbergh, V. W. M. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-011-0285-5 · Cited by 588
Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression
Cirri, P., & Chiarugi, P. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9340-x · Cited by 519
Activation of fibroblasts in cancer stroma
Räsänen, K., & Vaheri, A. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.04.032 · Cited by 499
“Activation of plasminogen to serine protease plasmin is mediated by urokinase-type plasminogen activator (uPA) and tissue plasminogen activator (tPA) [69].”
BackgroundHorowitz, A. M., Fan, X., Bieri, G., Smith, L. K., Sanchez-Diaz, C. I., Schroer, A. B., Gontier, G., Casaletto, K. B., Kramer, J. H., Williams, K. E., et al. (2020) · Science · doi:10.1126/science.aaw2622 · Cited by 496
The fat side of prostate cancer
Zadra, G., Photopoulos, C., & Loda, M. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.03.010 · Cited by 291
Fibroblasts as architects of cancer pathogenesis
Marsh, T., Pietras, K., & McAllister, S. S. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.10.013 · Cited by 264
Role of Urokinase Receptor in Tumor Progression and Development
Noh, H., Hong, S., & Huang, S. (2013) · Theranostics · doi:10.7150/thno.4218 · Cited by 129
Metrangolo, V., Ploug, M., & Engelholm, L. H. (2021) · Cancers · doi:10.3390/cancers13215376 · Cited by 44
“Besides uPAR’s well-established role in pericellular proteolysis, so-called non-proteolytic functions have emerged over the years, implying uPAR’s involvement in multiple intracellularsignaling pathways affecting several aspects of the neoplastic evolution such as cell proliferation, differentiation, survival, adhesio…”
BackgroundInfluentialYang, A., Dai, J., Xie, Z., Colman, R. W., Wu, Q., Birge, R. B., & Wu, Y. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302590 · Cited by 30
Molecular Network-Based Identification of Competing Endogenous RNAs in Thyroid Carcinoma
Lu, M., Xu, X., Xi, B., Dai, Q., Li, C., Su, L., Zhou, X., Tang, M., Yao, Y., & Yang, J. (2018) · Genes · doi:10.3390/genes9010044 · Cited by 25
“PLAU also plays crucial roles in tumor invasion and metastasis [68].”
Background
Metadata
- Authors
- Blasi, F., & Sidenius, N.
- Venue
- FEBS Letters
- Publisher
- Wiley
- Published
- 2009-12-27
- Volume
- 584
- Issue
- 9
- Pages
- 1923-1930
- ISSN
- 0014-5793 (ISSN-L)
- 1873-3468
- OpenAlex
- W2064911312
- Cited by
- 258
- References
- 104
- FWCI
- 6.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.